Scleroderma research starts with you. Learn more to find out if enrolling in the CONQUER registry is right for you!
In 2018, the SRF launched the CONQUER Registry—a first-of-its-kind nationwide patient registry and biosample repository designed to improve care and develop more effective, personalized treatments for scleroderma.
CONQUER brings together the largest scleroderma research centers across the U.S. to enroll thousands of patients from all backgrounds. By studying real-world data, researchers can uncover new insights into the disease and accelerate progress toward a cure.
Over 1,000 patients have already joined CONQUER—consider joining them. Every participant moves us one step closer to breakthroughs in scleroderma treatment.
